Brief: Avenira Reports Investment From Sichuan Hebang Biotechnology
10/03/2025 24:47
March 10 (Reuters) - Avenira Ltd AEV.AX: INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY INVESTMENT COMPRISES A$7.567 MILLION PLACEMENT AT AN ISSUE PRICE OF A$0.007 PER NEW SHARE Further company coverage: AEV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenira
See all newsAustralia's Avenira jumps most in more than 6 years on project development financing
Brief: Avenira Enters Facility Arrangements With Hebang For Up To A$85 Million
Australia's Avenira falls on discounted capital raising
Brief: Avenira Announces Renounceable Rights Issue
Brief: Avenira Formally Approved A$2.6M Exploration Budget To Advance Jundee South Gold Project